Regeneron
Trade Regeneron 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About REGN
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara.
REGN Key Statistics
Stock Snapshot
The current Regeneron(REGN) stock price is $926.00, with a market capitalization of 95.61B. The stock trades at a price-to-earnings (P/E) ratio of 20.23 and offers a dividend yield of 0.45%.
During the trading session on 2026-10-30, Regeneron(REGN) shares reached a daily high of $935.35 and a low of $839.08. At a current price of $926.00, the stock is +10.4% higher than the low and still -1.0% under the high.
Trading volume for Regeneron(REGN) stock has reached 2.85M, versus its average volume of 842.1K.
Over the past 52 weeks, Regeneron(REGN) stock has traded between a high of $935.35 and a low of $591.52.
Over the past 52 weeks, Regeneron(REGN) stock has traded between a high of $935.35 and a low of $591.52.
REGN News
...
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) stock hit a new 52-week high Friday after the biotechnology company reported better-than-expected third-quarter 202...
Regeneron Pharmaceuticals (REGN) announced an update on their ongoing clinical study. Regeneron (REGN) is launching a Phase 2 study called “Phase 2 Platform Tr...
Analyst ratings
65%
of 31 ratingsMore REGN News
Biotech Stocks To Watch: Regeneron Partner Has Breakout In Sight 10/14/2026 Boosted by its exclusive agreement with Regeneron, Kiniksa Pharmaceuticals stands a...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) will release its third quarter earnings report before the opening bell on Friday, Oct. 30. Analysts expect the Tar...
Regeneron Pharmaceuticals (REGN), Sanofi SA (SNY) announced an update on their ongoing clinical study. The Phase 1 study “Phase 1, Single Center, Open-label, R...
Regeneron Pharmaceuticals extended its BARDA agreement to supply additional Inmazeb Ebola treatment through 2031 for about US$270 million, while also reporting...
Investing Regeneron’s Billion-Dollar Catalyst Flying Under Wall Street’s Radar Ahead of Oct. 30 Earnings Regeneron (NASDAQ:REGN | REGN Price Prediction) reports...
Regeneron Pharmaceuticals (REGN) is back in focus after late-breaking C POST Phase 3 data at ESMO 2026 showed sustained disease-free survival and emerging overa...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.